SCHEMBL6943846

SCHEMBL6943846

CS(=O)(=O)N(NC(=O)[C@H](CC1CCC1)[C@H](CC=Cc1ccccc1)C(=O)NOC1CCCCO1)c1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADAM17 P78536 1/20 0.40
P2RX3 P56373 1/20 0.33
TGFBR1 P36897 1/20 0.32
METAP2 P50579 1/20 0.32
METAP1 P53582 1/20 0.32
CTSD P07339 4/20 0.32
ALDH1A1 P00352 1/20 0.32
GAA P10253 1/20 0.32
POLB P06746 1/20 0.31
MMP1 P03956 3/20 0.31
MMP2 P08253 3/20 0.31
MMP3 P08254 3/20 0.31
MMP8 P22894 3/20 0.31
MMP13 P45452 3/20 0.31
CTSC P53634 1/20 0.30
CCNA2 P20248 1/20 0.30
CDK2 P24941 1/20 0.30
CCNA1 P78396 1/20 0.30
CDK5 Q00535 1/20 0.30
CDK5R1 Q15078 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6942478 0.99 ADAM17 (0.41) ADAM17P2RX3TGFBR1METAP2METAP1
SCHEMBL6947352 0.91 ADAM17 (0.51) ADAM17P2RX3TGFBR1ALDH1A1GAA
SCHEMBL6939783 0.89 ADAM17 (0.37) ADAM17P2RX3TGFBR1ALDH1A1POLB
SCHEMBL6945960 0.87 ADAM17 (0.51) ADAM17P2RX3TGFBR1MMP2CA1
SCHEMBL6940024 0.86 ADAM17 (0.48) ADAM17CTSDALDH1A1POLBMMP1
SCHEMBL6943306 0.85 ADAM17 (0.45) ADAM17P2RX3TGFBR1GAAPOLB
SCHEMBL6942385 0.85 ADAM17 (0.45) ADAM17P2RX3TGFBR1ALDH1A1POLB
SCHEMBL6943824 0.84 ADAM17 (0.55) ADAM17ALDH1A1GAAPOLBMMP1
SCHEMBL6939403 0.84 ADAM17 (0.55) ADAM17ALDH1A1GAAPOLBMMP1
SCHEMBL6944673 0.84 ADAM17 (0.46) ADAM17P2RX3MMP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0993442-B1 HYDRAZINE DERIVATIVES HOFFMANN LA ROCHE (CH) 2003-04-23 EP disclosed
US-6235787-B1 ANTIINFLAMMATORY AGENTS; RHEUMATIC DISEASES; BONE DISORDERS; SKIN DISORDERS; MULTIPLE SCLEROSIS HOFFMANN-LA ROCHE INC. 2001-05-22 US disclosed